Rupcco Ltd is a pharmaceutical wholesaling and Distribution Company with a well structured franchise based distribution model as a means to consolidate its market for its goods and services. It has its head office located at Thika Town, Kenya Canners Plaza, third floor where it occupies a space of about 1000 square feet. The premises has been inspected by the pharmacy and poisons board and awarded with a valid wholesale/distribution dealer’s license. Rupcco has already ten established franchises whose principles have entered into agreement to single source from Rupcco central stores. The lead promoter of Rupcco ltd is Ruai Pharmaceuticals, a pharmaceutical company registered in the year 2007 under the laws of Kenya to carry on the business of Pharmaceutical distribution/wholesale retail among other activities. Ruai pharmaceuticals ltd has secured 20% shareholding and continues to anchor Rupcco Ltd to its conclusive registration and plays an important role in ensuring Rupcco is on growth phase. The pharmaceutical sector remains one of the most profitable areas of doing businesses in the East African region and beyond. In Kenya, the business has been boosted further by the provisions of the new constitution where the health functions have been devolved to the county government. Rupcco has a rare opportunity to trade with the forty seven (47) devolved government units. Kenya being the economic power house in East Africa region, coupled with its strategic location in the African continent makes it the destination of choice for pharmaceutical investors and Multinational Corporations eying Africa especially in the field of manufacturing and distribution. Kenya is currently the leading supplier of pharmaceutical products in the common market for eastern and southern Africa (COMESA) region, supplying about 50% of the region’s market. Kenya’s pharmaceutical industry is on a rebound, riding on the back of increased expenditure in healthcare and general economic growth over the years. It is for the above reasons that Rupcco has come up with an idea of playing a leading role in this fast growing industry. The business idea presents a noble business opportunity to savvy investors, both local and foreign, who wish to invest in the Kenya’s pharmaceutical industry and Africa at large where there is an enormous potential for quality and affordable generic drugs. Rupcco will need to raise a substantial capital to a tune of ksh350million to be able venture in this lucrative sector. Rupcco intends to invite strategic partners to invest in this business venture. The able management of Rupcco Ltd confidently promises its potential investors an annual return on investment ranging between 30 to 35 percent. The ongoing integration of East Africa States allowing for free movement labor, goods and other factors of production will generate new and unexploited market opportunities which the early adopters will benefit immensely. Countries like Tanzania, Uganda and Rwanda rely heavily on Kenya for supplies of pharmaceutical products. The three East African Countries import from Kenyan market an average of over 70% of pharmaceutical products consumed in those countries. The business model adopted by Rupcco Ltd will ensue value and responsiveness to the consumer, quality generics, high technology and innovation and unrivaled efficiency by employing economies of scale and acquiring fast moving generic products coupled by repackaging of fast mover products like hydrogen peroxide, calamine, G.V, tincture of iodine, glycerine, surgical spirit, methylated spirit,liquid paraffin among others.
